Skip to main content
Have a personal or library account? Click to login
Impact of resection depth on voice outcomes following transoral laser microsurgery for early glottic lesions Cover

Impact of resection depth on voice outcomes following transoral laser microsurgery for early glottic lesions

Open Access
|Oct 2026
Read online

Figures & Tables

FIGURE 1.

Patient flow diagram.

TABLE 1.

Demographic and clinical characteristics of patients

Laser cordectomy Type I; n = 13Laser cordectomy Type II/III; n = 16
Male, n (%)11 (84.6)15 (93.8)
Age at cordectomy, years, mean (SD)66.9 (5.3)68.0 (7.8)
Smoking before treatment, n (%)10 (76.9)11 (68.8)
Brinkman index, mean (SD)794.6 (700.9)593.8 (692.6)
Brinkman index, n (%)
  Light (0–199)4 (30.8)5 (31.3)
  Moderate (200–599)1 (7.7)4 (25.0)
  Heavy (≥ 600)8 (61.5)7 (43.8)
GERD symptoms, n (%)6 (46.2)4 (25.0)
Allergy, n (%)2 (15.4)2 (12.5)
Thyroid disease, n (%)1 (7.7)1 (6.3)
Neck spine issues, n (%)6 (46.2)3 (18.8)
Loud speech, n (%)7 (53.8)9 (56.3)
Fast speech tempo, n (%)4 (30.8)4 (25.0)
Vocal strain, n (%)
  Mild7 (53.8)7 (43.8)
  Moderate4 (30.8)4 (25.0)
  Severe2 (15.4)5 (31.3)
Hearing, n (%)
  Good12 (92.3)15 (93.8)
  Poor0 (0)1 (6.3)
  Hearing aid1 (7.7)0 (0)

[i] GERD = gastroesophageal reflux disease; SD = standard deviation

TABLE 4.

Objective assessments of vocal fold function and voice quality; by study group and time of measurement

Parameter / Patient groupBefore treatment1 month after treatment3 months after treatment12 months after treatmentP-value 1
Fundamental laryngeal frequency (F0), Hz
Cordectomy Type I156.19 ± 11.40 (147)170.49 ± 12.95 (154)166.58 ± 11.55 (165)164.27 ± 10.26 (150)0.562
Cordectomy Type II/III147.92 ± 10.29 (131)182.76 ± 16.12 (162)161.26 ± 10.56 (149)168.67 ± 11.61 (155)0.153
P-value 20.5950.5710.7370.7840.652
Jitter, %
Cordectomy Type I2.18 ± 0.60 (1.5)2.10 ± 0.51 (1.7)2.22 ± 0.52 (1.4)2.19 ± 0.44 (1.6)0.996
Cordectomy Type II/III3.73 ± 1.13 (1.8)5.04 ± 0.82 (4.2)3.84 ± 0.78 (2.9)4.06 ± 0.84 (3.1)0.519
P-value 20.2680.0080.1110.0750.606
Shimmer, %
Cordectomy Type I5.83 ± 1.29 (3.9)5.87 ± 0.90 (4.3)5.66 ± 0.87 (4.3)6.17 ± 0.89 (6.0)0.975
Cordectomy Type II/III8.53 ± 1.45 (6.4)12.76 ± 1.67 (11.0)7.68 ± 1.04 (7.7)9.06 ± 1.07 (7.9)0.010
P-value 20.1850.0010.1580.0530.057
Noise-to-harmonic ratio (NHR)
Cordectomy Type I0.17 ± 0.02 (0.13)0.16 ± 0.02 (0.15)0.15 ± 0.02 (0.14)0.16 ± 0.02 (0.14)0.837
Cordectomy Type II/III0.24 ± 0.05 (0.16)0.36 ± 0.06 (0.30)0.21 ± 0.04 (0.17)0.26 ± 0.04 (0.20)0.064
P-value 20.1920.0040.2020.0700.133
Soft phonation index (SPI)
Cordectomy Type I17.38 ± 2.46 (15.8)16.90 ± 3.04 (13.6)18.05 ± 1.70 (17.4)13.71 ± 2.14 (10.2)0.482
Cordectomy Type II/III18.65 ± 2.76 (17.8)12.20 ± 2.02 (10.8)21.40 ± 3.17 (18.1)14.59 ± 1.81 (13.6)0.005
P-value 20.7390.1950.3630.7540.221
Voice turbulence index (VTI)
Cordectomy Type I0.06 ± 0.02 (0.05)0.06 ± 0.01 (0.04)0.05 ± 0.01 (0.04)0.06 ± 0.01 (0.06)0.693
Cordectomy Type II/III0.08 ± 0.01 (0.06)0.14 ± 0.02 (0.11)0.10 ± 0.03 (0.06)0.11 ± 0.03 (0.07)0.099
P-value 20.5000.0100.0890.0990.196
Maximum phonation time (MPT), seconds
Cordectomy Type I13.9 ± 0.9 (14)14.9 ± 1.5 (13.0)16.3 ± 1.9 (14.0)16.2 ± 1.1 (15.0)0.341
Cordectomy Type II/III13.9 ± 1.2 (13.5)9.8 ± 1.0 (9.5)8.5 ± 0.8 (8.0)12.9 ± 1.4 (13.0)0.002
P-value 20.9550.0060.0020.1000.001
Mean loudness (ML), dB
Cordectomy Type I57.40 ± 1.49 (56.4)58.33 ± 1.84 (58.2)60.46 ± 1.38 (58.4)57.07 ± 1.59 (58.0)0.191
Cordectomy Type II/III54.76 ± 1.70 (55.1)55.48 ± 3.14 (53.9)59.05 ± 1.49 (58.2)60.05 ± 1.39 (60.6)0.087
P-value 20.2630.4670.5010.1680.206
S/Z Ratio
Cordectomy Type I1.04 ± 0.06 (1.0)1.01 ± 0.02 (1.0)0.93 ± 0.04 (1.0)0.94 ± 0.05 (1.0)0.240
Cordectomy Type II/III1.04 ± 0.04 (1.0)1.58 ± 0.24 (1.3)1.26 ± 0.13 (1.0)1.20 ± 0.11 (1.0)0.048
P-value 20.9810.0290.0260.0370.071
Reflux symptom index (RSI)
Cordectomy Type I10.5 ± 2.3 (8.0)7.8 ± 1.5 (8.0)7.9 ± 1.4 (9.0)7.9 ± 1.7 (6.0)0.324
Cordectomy Type II/III10.3 ± 1.9 (8.0)10.9 ± 1.8 (9.0)8.6 ± 1.6 (7.5)7.3 ± 1.4 (5.5)0.045
P-value 20.9230.2020.7740.7820.278
Reflux finding score (RFS)
Cordectomy Type I7.1 ± 1.5 (5.0)6.5 ± 1.3 (5.0)6.5 ± 1.1 (5.0)4.2 ± 1.0 (4.0)0.014
Cordectomy Type II/III5.5 ± 1.2 (7.0)6.2 ± 1.4 (6.5)6.5 ± 1.3 (6.0)5.6 ± 0.9 (5.5)0.664
P-value 20.4120.8540.9820.3430.184
Muscle tension dysphonia (MTD), n (%)
Cordectomy Type I2/13 (15.4)3/13 (23.1)3/13 (23.1)2/13 (15.4)1
Cordectomy Type II/III3/16 (18.8)7/16 (43.8)7/16 (43.8)8/16 (50.0)0.068
P-value 20.9810.0290.0260.0370.071
Reflux symptom index (RSI)
Cordectomy Type I10.5 ± 2.3 (8.0)7.8 ± 1.5 (8.0)7.9 ± 1.4 (9.0)7.9 ± 1.7 (6.0)0.324
Cordectomy Type II/III10.3 ± 1.9 (8.0)10.9 ± 1.8 (9.0)8.6 ± 1.6 (7.5)7.3 ± 1.4 (5.5)0.045
P-value 20.9230.2020.7740.7820.278
Reflux finding score (RFS)
Cordectomy Type I7.1 ± 1.5 (5.0)6.5 ± 1.3 (5.0)6.5 ± 1.1 (5.0)4.2 ± 1.0 (4.0)0.014
Cordectomy Type II/III5.5 ± 1.2 (7.0)6.2 ± 1.4 (6.5)6.5 ± 1.3 (6.0)5.6 ± 0.9 (5.5)0.664
P-value 20.4120.8540.9820.3430.184
Muscle tension dysphonia (MTD), n (%)
Cordectomy Type I2/13 (15.4)3/13 (23.1)3/13 (23.1)2/13 (15.4)1
Cordectomy Type II/III3/16 (18.8)7/16 (43.8)7/16 (43.8)8/16 (50.0)0.068
P-value 210.4330.4330.114-
Intensity of scarring, n (%)
Cordectomy Type I0.667
  Mild-11 (84.6)10 (76.9)12 (92.3)
  Moderate-2 (15.4)3 (23.1)1 (7.7)
  Severe-0 (0)0 (0)0 (0)
Cordectomy Type II/III1
  Mild-10 (62.5)11 (68.8)11 (68.8)
  Moderate-4 (25.0)4 (25.0)4 (25.0)
  Severe-2 (12.5)1 (6.3)1 (6.3)
P-value 2-0.47710.343-

1 Comparison between measurement within patient group;

2 Comparison between patient groups within measurement;

3 Interaction between main factors (patient group, measurement)

Unless otherwise specified, the data are presented as mean ± standard error (median).

TABLE 3.

Videostroboscopic assessments of vocal fold function; by study group and time of measurement

Parameter / Patient groupBefore treatment1 month after treatment3 months after treatment12 months after treatmentP-value1
Vocal fold vibratory amplitude
Cordectomy Type I0.002
  Appropriate0 (0)1 (7.7)3 (23.1)5 (38.5)
  Diminished8 (61.5)6 (46.2)7 (53.8)6 (46.2)
  Absent5 (38.5)6 (46.2)3 (23.1)2 (15.4)
Cordectomy Type II/III0.002
  Appropriate1 (6.3)0 (0)0 (0)0 (0)
  Diminished2 (12.5)2 (12.5)7 (43.8)10 (62.5)
  Absent13 (81.3)14 (87.5)9 (56.3)6 (37.5)
P-value 20.0160.0410.0490.022-
Vocal fold phase symmetry
Cordectomy Type I0.024
  Symmetrical0 (0)0 (0)2 (15.4)4 (30.8)
  Asymmetrical13 (100)13 (100)11 (84.6)9 (69.2)
Cordectomy Type II/III0.572
  Symmetrical1 (6.3)0 (0)0 (0)1 (6.3)
  Asymmetrical15 (93.8)16 (100)16 (100)15 (93.8)
P-value 21-0.1920.144-
Vocal fold vibration regularity
Cordectomy Type I0.024
  Regular0 (0)0 (0)2 (15.4)4 (30.8)
  Irregular13 (100)13 (100)11 (84.6)9 (69.2)
Cordectomy Type II/III0.572
  Regular1 (6.3)0 (0)0 (0)1 (6.3)
  Irregular15 (93.8)16 (100)16 (100)15 (93.8)
P-value 21-0.1920.144-
Vocal fold closure
Cordectomy Type I0.003
  Complete2 (15.4)2 (15.4)4 (30.8)5 (38.5)
  Brief5 (38.5)5 (38.5)8 (61.5)7 (53.8)
  Absent6 (46.2)6 (46.2)1 (7.7)1 (7.7)
Cordectomy Type II/III0.338
  Complete2 (12.5)2 (12.5)2 (12.5)3 (18.8)
  Brief6 (37.5)3 (18.8)8 (50.0)8 (50.0)
  Absent8 (50.0)11 (68.8)6 (37.5)5 (31.3)
P-value 210.4500.1450.259-
Mucosal wave movement
Cordectomy Type I0.001
  Normal0 (0)0 (0)3 (23.1)5 (38.5)
  Disturbed8 (61.5)7 (53.8)7 (53.8)6 (46.2)
  Absent5 (38.5)6 (46.2)3 (23.1)2 (15.4)
Cordectomy Type II/III0.001
  Normal0 (0)0 (0)0 (0)1 (6.3)
  Disturbed4 (25.0)3 (18.8)9 (56.3)10 (62.5)
  Absent12 (75.0)13 (81.3)7 (43.8)5 (31.3)
P-value 20.0670.0640.1250.126-

1 Comparison between measurement within patient group;

2 Comparison between patient groups within measurement;

3 Interaction between main factors (patient group, measurement)

Data are frequencies (%).

TABLE 2.

Patient assessment of voice quality and satisfaction; by study group and time of measurement

Parameter / Patient groupBefore treatment1 month after treatment3 months after treatment12 months after treatmentP-value 1
Voice quality (VAS)
Cordectomy Type I4.8 (0.5)3.9 (0.5)3.5 (0.5)3.0 (0.4)0.040
Cordectomy Type II/III5.6 (0.3)5.7 (0.6)4.3 (0.6)3.6 (0.5)0.031
P-value 20.3420.0320.2790.367P-value3 = 0.635
Voice handicap index score (VHI)
Cordectomy Type I26.9 (7.9)19.5 (4.9)15.7 (5.2)9.2 (3.6)0.041
Cordectomy Type II/III31.6 (6.0)41.0 (6.8)24.4 (6.3)26.6 (7.5)0.016
P-value 20.4040.0390.2100.195P-value3 = 0.263

1 Comparison between measurement within patient group;

2 Comparison between patient groups within measurement;

3 Interaction between main factors (patient group, measurement); VAS = visual analog scale; VHI = voice handicap index

Data are mean values (standard errors)

FIGURE 2.

Visual Analogue Scale (VAS) evolution during follow-up.

FIGURE 3.

Voice Handicap Index (VHI) evolution during follow-up.

TABLE 5.

Exploratory comparison between classical full-length type I cordectomy and limited mucosal resections within Group 1

VariableFull-length Type I CordectomyMean of Type I Cordectomy With Partial Mucosal
Preservation Group
SDz-score
Mean loudness (ML) preoperative (dB)46.4258.324.42−2.69
Fundamental laryngeal frequency (F0) 1 month postoperatively (Hz)266.45162.4938.34+2.71
Jitter, 1 month postoperatively (%)6.8771.7001.211+4.28
Mean loudness (ML) 1 month postoperatively (dB)43.4259.575.12−3.15
Noise-to-harmonic ratio (NHR) 1 month postoperatively0.3000.1520.041+3.61
Fundamental laryngeal frequency (F0) 3 months postoperatively (Hz)276.17157.4526.65+4.46
Jitter, 3 months postoperatively (%)5.6751.9351.612+2.32
Voice turbulence index (VTI) 3 months postoperatively0.1230.0450.018+4.38
Fundamental laryngeal frequency (F0) 12 months postoperatively (Hz)254.02156.7926.45+3.68
Jitter, 12 months postoperatively (%)5.4571.9131.300+2.73
Shimmer, 12 months postoperatively (%)14.6515.4652.008+4.57
Noise-to-harmonic ratio (NHR) 12 months postoperatively0.3410.1460.036+5.36
DOI: https://doi.org/10.2478/raon-2026-0052 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Submitted on: Apr 30, 2026
Accepted on: May 29, 2026
Published on: Oct 22, 2026
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2026 Miha Zabret, Marc Remacle, Maja Sereg Bahar, Ales Groselj, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.